Clonazepam Tablets

Description

Clonazepam Tablets (0.25mg / 0.5mg / 1mg / 2mg)

Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)

1. Product Introduction

Healthy Life Pharma Pvt. Ltd. is a specialized manufacturer of Clonazepam Tablets in India. Clonazepam is a long-acting benzodiazepine with anticonvulsant and anxiolytic properties. It is prescribed for selected seizure disorders and panic disorder according to approved indications. Because Clonazepam is a controlled psychotropic medicine in many jurisdictions, manufacture, distribution and export require applicable licenses and regulatory controls.

2. Product Specifications

3. Manufacturing Technology

• Content Uniformity: High-precision dispensing and validated geometric blending are important for consistent low-dose Clonazepam tablets.
• Mouth-Dissolving Presentations: Where separately registered, rapidly disintegrating formulations use validated excipients and specifications. They should not be presented as emergency seizure-rescue treatment unless specifically approved for that purpose.
• Dissolution: API characteristics, excipients and compression parameters are controlled to meet the registered release profile.
• Controlled Logistics: Manufacture and export are handled only under the permits and psychotropic-drug requirements applicable to the relevant markets.

4. Quality Assurance

• Dissolution / Disintegration: Tested according to the applicable dosage-form specification.
• Assay & Content Uniformity: Potency and dosage-unit uniformity are verified against approved limits.
• Related Substances: Relevant impurities and degradation products are monitored during release and stability testing.

5. Clonazepam Pharmacology and Uses

Clonazepam binds to benzodiazepine sites on GABA-A receptors and enhances inhibitory GABAergic neurotransmission. This reduces neuronal excitability and contributes to its anticonvulsant and anxiolytic effects.

• Seizure Disorders: Used for selected epileptic seizure types according to local approved indications and specialist assessment.
• Panic Disorder: Used for panic disorder in markets where this indication is approved.
• Other Uses: Conditions such as restless legs syndrome or certain movement disorders may involve off-label use in some settings and require clinician assessment.

6. Export and Regulatory Support

• Dossier Support: CTD / ACTD documentation where applicable.
• Certificates: FSC, COPP and COA where applicable.
• Psychotropic Documentation: Import/export permits and controlled-drug documentation are handled where legally required and appropriately licensed.
• Logistics: International shipment according to applicable destination-market requirements.

7. Frequently Asked Questions

Q: Who manufactures Clonazepam Tablets?
A: Healthy Life Pharma Pvt. Ltd. manufactures Clonazepam tablet formulations in India, subject to applicable permissions.

Q: Is Clonazepam sold under different brand names?
A: Yes. It is marketed under various brands internationally. Generic equivalence and interchangeability depend on the registered formulation and local regulatory requirements.

Q: Can Clonazepam cause dependence?
A: Yes. Benzodiazepines can cause physical dependence and withdrawal. Abrupt discontinuation after continued use can trigger serious symptoms, including seizures, so tapering should be medically supervised.

Q: Can alcohol be used with Clonazepam?
A: Alcohol should be avoided because combining CNS depressants can markedly increase sedation and breathing impairment.

Clinical Pharmacology & Safety Information

(For Registered Medical Practitioners & Patient Reference)

8. Dosage and Administration

• Dose: Initiation, titration and maintenance depend on indication, age, clinical response, concomitant medicines and approved prescribing information.
• Pediatric Use: Pediatric dosing must follow specialist advice and the age/weight recommendations in the registered label.
• Administration: Use conventional or mouth-dissolving presentations only according to their specific instructions.
• Discontinuation: Do not stop abruptly after continued use; gradual clinician-directed tapering may be required.

9. Side Effects and Precautions

• CNS: Drowsiness, dizziness, ataxia, slowed reaction time and memory or cognitive impairment can occur.
• Respiratory Depression: Combining benzodiazepines with opioids, alcohol or other CNS depressants can cause profound sedation, respiratory depression, coma or death.
• Dependence & Withdrawal: Physical dependence can develop. Abrupt discontinuation or rapid dose reduction can cause serious withdrawal, including seizures.
• Respiratory Conditions: Extra caution is required in patients with significant respiratory impairment or sleep-related breathing disorders.
• Paradoxical Reactions: Agitation, irritability or disinhibition can occur rarely and require clinical review.

10. Storage Instructions

• Store below 25°C in a dry place.
• Protect from moisture and excessive heat.
• Keep in the original packaging.
• Keep strictly out of reach of children.